Nanotechnology offers innovative solutions for the diagnosis of Fragile X Syndrome. Nanoparticles can be engineered to bind to specific genetic markers of the FMR1 mutation. These nanoparticles can then be detected using advanced imaging techniques, offering quicker and more accurate diagnosis compared to traditional methods.
